425: Strive CEO Updates on Semler Scientific Merger

Strive's CEO Matthew Cole posted on X.com regarding the proposed business combination with Semler Scientific, Inc., accompanied by a cautionary statement.

Summary

• Strive, Inc. CEO Matthew Cole posted on X.com on November 12, 2025, concerning the proposed business combination with Semler Scientific, Inc.
• The communication serves as a cautionary statement regarding forward-looking statements related to the merger.
• It highlights the availability of additional information, including the Registration Statement on Form S-4, which contains an Information Statement/Proxy Statement/Prospectus.
• Investors and stockholders are urged to read these documents before making voting or investment decisions.
• The filing also identifies participants in the solicitation of proxies from Semler Scientific stockholders.

Sentiment

Score: 5

Explanation: The filing is a standard legal disclosure regarding a proposed business combination, focusing on cautionary statements and procedural information rather than performance or specific positive/negative news.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.

Risks

• The occurrence of any event, change, or circumstance that could lead to the termination of the merger agreement between Strive and Semler Scientific.
• The possibility that the proposed transaction may not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all, including as a result of changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact anticipated benefits.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The proposed transaction is expected to result in strategic and financial benefits for the combined company, including successful integration of businesses and positive impacts on future financial performance. However, these are forward-looking statements subject to significant risks and uncertainties.

Management Comments

• Matthew Cole, CEO of Strive, Inc., posted a communication on X.com on November 12, 2025, in connection with the proposed business combination with Semler Scientific.

Industry Context

The filing mentions risks associated with "Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets," suggesting that the combined entity may be involved in or exposed to the evolving trend of corporate adoption of digital assets for treasury management. This positions the merger within a broader context of companies exploring or integrating digital asset strategies.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk factor.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is set forth in its definitive proxy statement filed on July 17, 2025.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock.
• Customers and employees of both Strive and Semler Scientific may have adverse reactions or experience changes to business or employee relationships as a result of the transaction.

Next Steps

• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders.
• Semler Scientific stockholders will be asked to approve the proposed transaction.
• Strive and Semler Scientific may file other relevant documents with the SEC concerning the proposed transaction.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Bitcoin Treasury, Digital Assets, Corporate Governance, Risk Factors, Shareholder Approval